Bicara Therapeutics

Bicara Therapeutics develops dual-action oncology immunotherapies. 

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2024
Stage of Initial Investment
Series B
Initial Investment Year
2023
Bicara Portco Hover Image